HCA Healthcare Inc.
06/18/2026 | Press release | Distributed by Public on 06/18/2026 07:12
Management Change/Compensation (Form 8-K)
| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the "Company") agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027. Dr. Cuffe will be eligible to receive benefits according to the Company's executive severance policy and applicable incentive plans.
HCA Healthcare Inc. published this content on June 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 18, 2026 at 13:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]